FDA Inspection 998184 — Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)
The FDA completed an inspection of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) on November 2, 2016 in Lianyungang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 2, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)